What is the share price of Elder Pharmaceuticals Ltd (ELDERPHARM)?

Company share prices are keep on changing according to the market conditions. The current trading price of Elder Pharmaceuticals Ltd (ELDERPHARM) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Elder Pharmaceuticals?

The latest standalone P/E ratio of Elder Pharmaceuticals as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Elder Pharmaceuticals Ltd (ELDERPHARM)?

The latest standalone P/B ratio of Elder Pharmaceuticals Ltd (ELDERPHARM) as of 01-Jan-1970 is 0.13.

What is the 52-week high and low of Elder Pharmaceuticals Ltd (ELDERPHARM)?

The 52-week high of Elder Pharmaceuticals Ltd (ELDERPHARM) is Rs. 38.00 and the 52-week low is Rs. 37.10.

Elder Pharmaceuticals Ltd (ELDERPHARM) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Elder Pharmaceuticals Ltd (ELDERPHARM)
Brand: Elder Pharmaceuticals

Elder Pharmaceuticals Ltd (ELDERPHARM)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532322 NSE: ELDERPHARM Pharmaceuticals & Drugs | Small Cap | Elder Pharma Share Price

Elder Pharmaceuticals Ltd (ELDERPHARM)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532322 NSE: ELDERPHARM Pharmaceuticals & Drugs | Small Cap | Elder Pharma Share Price

Key Metrics

Valuation Multiples

Market Cap

₹78 Cr.

Current Price

₹0

52-Week Low / High

₹37 / 38

TTM EPS

₹-30.2

TTM Sales

₹233 Cr.

Book Value per Share

₹299.2

P/E Ratio

0.00

Industry PE

Price to Book (P/B)

0.13

Price to Sales (P/S)

0.34

EV/EBITDA

-0.64

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

1.01%

Return on Capital Employed (ROCE)

16.85%

Return on Assets (ROA)

0.38%

Operating Profit Margin

-13.4%

Net Profit Margin

1.64%

Gross Profit Margin

-68.3%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

-50.99%

Operating Profit Growth (1 Year)

-132.74%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

-91.55%

Asset Quality

Promoter Holding

25.34%

Pledged shares (%) of Promoter's holding (%)

84.69%

Reserves

₹594 Cr.

Equity

₹20.5 Cr.

Face Value

₹10

All Time Low / High

₹20.35 / 474.00

Elder Pharmaceuticals stock performance

Key Ratios

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Jun'13	Jun'14	TTM
ROCE % ⓘ	15.1%	15.5%	15.1%	15.9%	12.5%	12.5%	12.7%	13.1%	14.5%	16.9%	-
Growth Parameters ⓘ
Sales ⓘ	285	355	449	551	620	703	839	985	986	483	233
Sales YoY Gr.	-	24.4%	26.6%	22.7%	12.5%	13.4%	19.3%	17.4%	0.2%	-51%	-
Adj EPS ⓘ	12	21.1	28.4	36.6	27.4	31.2	36.2	43.2	37.6	-117.8	-30.2
YoY Gr.	-	75.7%	35%	28.6%	-25.2%	14.2%	15.9%	19.3%	-12.9%	-413.1%	-
BVPS (₹) ⓘ	124.2	146.3	172.8	203.9	220.2	251.7	297.6	336.8	303	382.5	299.2
Adj Net Profit ⓘ	19.2	36.8	52.8	68.8	51.6	58.9	74.3	88.6	77.3	-242	-62
Cash Flow from Ops. ⓘ	-10.3	-5.3	70.9	-37.4	62.2	8.9	61.8	19.5	-25.5	1,153	-
Debt/CF from Ops. ⓘ	-12.8	-37.6	3.3	-9.1	6.4	62.2	12.1	45.4	-35.7	0.5	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	6%	-4.9%	-16.8%	-51%
Adj EPS ⓘ	-228.9%	-233.9%	-248.2%	-413.1%
BVPSⓘ	13.3%	11.7%	8.7%	26.3%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Jun'13	Jun'14	TTM
Return on Equity % ⓘ	12.6	16.1	18.2	19.4	12.9	13.2	13.7	13.6	13.1	-30.9	-8.9
Op. Profit Mgn % ⓘ	14.7	17.1	17.4	19.1	16.3	18.4	21	20.6	21.8	-13.4	-95.3
Net Profit Mgn % ⓘ	6.7	10.4	11.8	12.5	8.3	8.4	8.9	9	7.8	-50	-26.7
Debt to Equity ⓘ	0.7	0.8	0.7	0.9	1	1.2	1.2	1.3	1.5	0.8	-
Working Cap Days ⓘ	261	243	231	212	232	250	257	281	327	755	415
Cash Conv. Cycle ⓘ	148	143	132	109	117	132	137	147	122	179	-82

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Jun'13	Jun'14
Sales	285.34	354.83	449.25	551.20	620.02	702.79	838.59	984.69	1,233.10	483.47
Operating Expenses ⓘ +	243.45	294.23	371.25	445.87	520.65	578.19	662.78	782.53	964.03	571.58
Manufacturing Costs	19.42	31.63	35.54	43.41	44.82	50.66	35.38	39.98	47.33	34.19
Material Costs	144.79	160.87	203.20	244.62	278.97	304.54	368.66	471.35	573.09	308.35
Employee Cost	31.37	40.90	55.89	67.21	83.37	90.67	104.33	108.98	151.43	112.39
Other Costs ⓘ	47.87	60.84	76.62	90.63	113.50	132.31	154.40	162.22	192.17	116.65
Operating Profit ⓘ	41.89	60.60	78	105.33	99.37	124.61	175.81	202.16	269.07	-88.10
Operating Profit Margin (%)	14.7%	17.1%	17.4%	19.1%	16.0%	17.7%	21.0%	20.5%	21.8%	-18.2%
Other Income ⓘ +	6.54	5.93	7.46	7.59	8.14	7.63	8.04	24.31	26.22	15.13
Exceptional Items ⓘ	0	0	0	0	0	0	-5.01	-6.29	-5.09	380.04
Interest ⓘ	14.02	14.13	15.58	23.73	37.39	50.78	62.90	89.02	137.97	260.06
Depreciation ⓘ	4.17	5.55	8.79	10.61	11.52	16.77	26.87	27.64	36.52	29.16
Profit Before Tax ⓘ	30.24	46.85	61.10	78.58	58.59	64.68	89.07	103.51	115.70	17.85
Tax ⓘ	9.85	10.15	8.33	9.93	7.95	9.29	18.28	19.44	21.97	9.93
Profit After Tax	20.39	36.70	52.77	68.65	50.64	55.39	70.79	84.07	93.74	7.92
PAT Margin (%)	7.2%	10.3%	11.8%	12.5%	8.2%	7.9%	8.4%	8.5%	7.6%	1.6%
Adjusted EPS (₹)	12.8	21.0	28.4	36.5	26.9	29.4	34.5	40.9	45.6	3.9
Dividend Payout Ratio (%)	19.60%	11.90%	8.80%	6.80%	9.30%	10.20%	8.70%	7.30%	0%	0%

Valuation of Elder Pharma - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Jun'13	Jun'14
Equity and Liabilities
Shareholders Fund +	198.75	255.58	320.99	383.12	415.33	474.67	611.12	691.76	777.83	785.59
Share Capital ⓘ	16.02	17.50	18.60	18.82	18.89	18.89	20.57	20.57	20.57	20.57
Reserves ⓘ	182.73	238.08	302.39	364.30	396.44	455.78	590.55	671.19	757.26	765.03
Debt +	131.87	197.69	236.52	341.59	400.14	555.68	679.76	780.87	972.26	544.64
Long Term Debt	131.87	197.69	236.52	341.59	400.14	555.68	375.44	423.97	573.63	349.10
Short Term Debt	0	0	0	0	0	0	304.32	356.90	398.63	195.54
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	23.14	29.49	39.11	32.71	32.30	37.87	44.31	43.83	68.06	33.83
Others Liabilities ⓘ	56.82	67.79	76.39	60.43	86.24	86.92	164.61	197.88	389.38	571.69
Total Liabilities ⓘ	410.58	550.55	673.01	817.84	934.01	1,155.13	1,499.80	1,714.34	2,207.53	1,935.74
Fixed Assets
Net Fixed Assets ⓘ +	63.78	89.94	140.30	169.17	171.26	465.31	475.77	507.61	484.23	434.91
Gross Block	82.08	113.37	172.38	211.53	224.87	535.40	570.94	630.07	642.97	599.80
Accumulated Depreciation	18.30	23.43	32.08	42.36	53.61	70.10	95.17	122.46	158.74	164.89
CWIP ⓘ	29.25	94.92	137.19	163.36	252.15	65.74	93.03	191.01	268.36	304.26
Investments ⓘ	45.13	42.76	37.53	61.89	3.93	19.68	10.87	21.09	3.90	3.73
Inventories	96.35	107.07	93.26	83.68	88.11	142.56	184.90	221.25	159.26	27.90
Trade Receivables	61.53	108.20	122.43	139.55	177.63	193.24	226.66	284.47	328.37	84.47
Cash Equivalents ⓘ	48.84	36.52	56.44	66.71	63.79	77.31	251.67	129.34	87.83	538.39
Others Assets ⓘ	65.70	71.15	85.86	133.49	177.14	191.30	256.89	359.57	875.58	542.09
Total Assets ⓘ	410.58	550.55	673.01	817.84	934.01	1,155.13	1,499.80	1,714.34	2,207.53	1,935.74

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Jun'13	Jun'14
Cash Flow From Operating Activity ⓘ +	-10.29	-5.25	70.93	-37.44	62.15	8.93	61.82	19.48	-31.93	1,153.39
PBT ⓘ	30.24	46.85	61.10	78.58	58.59	64.68	89.07	103.51	120.79	-362.19
Adjustment ⓘ	11.55	13.33	16.76	26.42	41.97	64.40	82.77	100.46	144.28	668.69
Changes in Working Capital ⓘ	-28.31	-40.25	19.94	-109.51	8.58	-58.87	-91.41	-163.4	-272.5	856.16
Tax Paid ⓘ	-9.75	-11.06	-11.29	-9.20	-9.60	-10.50	-18.61	-21.09	-24.50	-9.26
Cash Flow From Investing Activity ⓘ +	-50.66	-88.66	-88.59	-82.08	-37.50	-137	-47.42	-145.18	-48.17	-14.99
Capex	-34.37	-96.96	-101.29	-65.32	-102.13	-124.13	-64.65	-157.68	-90.50	-28.32
Net Investments	-22.84	2.37	5.23	-24.36	57.96	-15.75	8.80	-10.22	17.20	0.17
Others ⓘ	6.54	5.93	7.46	7.59	6.67	2.88	8.43	22.72	25.14	13.17
Cash Flow From Financing Activity ⓘ +	76.52	81.59	37.57	129.80	-27.57	141.59	159.97	3.36	38.59	-687.85
Net Proceeds from Shares ⓘ	80.11	26.67	21.64	7.54	0	0	69.70	0	0	0
Net Proceeds from Borrowing ⓘ	0.47	59.90	21	137.91	-21.59	147.11	62.14	48.54	149.66	-224.53
Interest Paid ⓘ	0	0	0	0	0	0	-59.29	-89.02	-137.97	-260.06
Dividend Paid ⓘ	-3.60	-4.37	-4.64	-4.66	-4.71	-4.71	-5.66	-6.16	-6.16	0
Others ⓘ	-0.47	-0.61	-0.42	-10.98	-1.27	-0.80	93.08	50.01	33.07	-203.25
Net Cash Flow ⓘ	15.56	-12.32	19.91	10.28	-2.92	13.52	174.36	-122.34	-41.50	450.55

Financial Ratio

PARTICULARS	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Jun'13	Jun'14
Ratios
ROE (%)	13.47	16.16	18.31	19.5	12.69	12.45	13.04	12.91	12.76	1.01
ROCE (%)	15.08	15.5	15.1	15.9	12.45	12.51	12.72	13.12	14.53	16.85
Asset Turnover Ratio	0.82	0.8	0.76	0.76	0.72	0.68	0.64	0.62	0.64	0.24
PAT to CFO Conversion(x)	-0.5	-0.14	1.34	-0.55	1.23	0.16	0.87	0.23	-0.34	145.63
Working Capital Days
Receivable Days	88.50	80.90	90.80	84.30	91.90	95.40	90.30	93.80	89.80	154.50
Inventory Days	101.80	96.90	78.90	56.90	49.80	59.30	70.40	74.50	55.80	70.10
Payable Days	71.80	59.70	61.60	53.60	42.50	42.10	40.70	34.10	35.60	60.30

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

99.42

99.17

95.30

91.49

89.94

77.73

77.56

85.06

84.73

84.69

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Elder Pharmaceuticals Ltd FAQs

The current trading price of Elder Pharma on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Elder Pharma stood at ₹78.04 Cr

The latest P/E ratio of Elder Pharma as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Elder Pharma as of 31-Dec-1969 is 0.13.

The 52-week high of Elder Pharma is ₹38.00 and the 52-week low is ₹37.10.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Elder Pharma is ₹233 ( Cr.) .

Data is not available for this company.

No data found

About Elder Pharmaceuticals Ltd

Elder Pharmaceuticals was incorporated in the year 1983 and commenced operations in 1989. The company is engaged into manufacturing and marketing of prescription pharmaceutical brands, surgical and medical devices.

Elder is one the leading companies in the pharmaceutical formulation market in India. It holds market leader position in three therapeutic segments - Womenâ€™s Healthcare, Wound Care and Nutraceuticals.

Products

Elder manufactures API and formulations spread across 4 manufacturing plants in India and one in Nepal. It manufactures various dosage forms like tablets, capsules, syrups, injectables, topical creams and ointments.

It manufactures wide range of pharmaceutical brands such as Thrive G, Formic, Carnitor, Tanatril, B-long, Cranbe, Bonviva etc.

Company Shelcal brand is one of the top brands in the Indian pharmaceutical industry.

Awards

The company was awarded Amity Corporate Excellence Award for the year 2008

Elder was also honoured Frost & Sullivan Market Leadership Award for its 'Shelcal' brand for the year 2008.

It was among the Forbes list of 'Asia's 200 Best under a billion' over a period of three years.

It has subsidiary namely Elder International FZCO in Dubai, Somerta Holdings Company in Cyprus and Elder Biomeda EDA in Bulgaria.

In 2012 - Joint Managing Director Mr Alok Saxena has been bestowed with â€œBrand Slam Leadership Awardâ€ on 13th Oct, 2012 by Indira Group of Institutes, Pune.
- Elder Pharma is awarded India's Most Admired Nutrition and Neutraceutical Company of the Year 2012
-Elder Pharmaceuticals Limited is awarded with CIO100 Award.
-Elder Pharma join hands with Swedish firm Sterisol AB

Elder Pharmaceuticals Ltd (ELDERPHARM)

Elder Pharmaceuticals Ltd (ELDERPHARM)

Elder Pharmaceuticals stock performance

10 Year X-Ray :